Effects of zoledronate on bone mineral density and bone turnover after long-term denosumab therapy: Observations in a real-world setting
Author:
Funder
Sandoz
Novartis
Publisher
Elsevier BV
Subject
Histology,Physiology,Endocrinology, Diabetes and Metabolism
Reference24 articles.
1. Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass;Bone;J. Clin. Endocrinol. Metab.,2011
2. Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial;Miller;Bone,2008
3. Clinical features of 24 patients with rebound-associated vertebral fractures after denosumab discontinuation: systematic review and additional cases;Anastasilakis;J. Bone Miner. Res.,2017
4. Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension;Cummings;J. Bone Miner. Res.,2018
5. Risk factors for vertebral fractures and bone loss after denosumab discontinuation: a real-world observational study;Everts-Graber;Bone,2021
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Letter to the Editor From Fitzpatrick et al: “Zoledronate After Denosumab Discontinuation: Is Repeated Administrations More Effective Than A Single Infusion?”;The Journal of Clinical Endocrinology & Metabolism;2024-07-15
2. The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland;Osteoporosis International;2024-06-26
3. Positive und negative (Neben)Effekte bei Osteoporose-Sequenztherapie;Osteologie;2024-05
4. Three-year effect of bisphosphonates on bone mineral density after denosumab withdrawal: observations from a real-world study;JBMR Plus;2024-04-30
5. Zoledronate After Denosumab Discontinuation: Is Repeated Administrations More Effective Than Single Infusion?;The Journal of Clinical Endocrinology & Metabolism;2024-04-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3